Protein Expression Modifications in Phage-Resistant Mutants of Aeromonas salmonicida after AS-A Phage Treatment.

scientific article published on 8 March 2018

Protein Expression Modifications in Phage-Resistant Mutants of Aeromonas salmonicida after AS-A Phage Treatment. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/ANTIBIOTICS7010021
P932PMC publication ID5872132
P698PubMed publication ID29518018

P50authorNádia OsórioQ63811978
Catarina MoreirinhaQ40776796
Adelaide AlmeidaQ40776867
P2093author name stringCarla Pereira
Ivonne Delgadillo
Sara Simões
P2860cites workEffects of UV radiation on the lipids and proteins of bacteria studied by mid-infrared spectroscopyQ50974872
Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation.Q54314098
Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experimentsQ56926765
Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelisQ73054396
Analysis of microbial components using LC-IRQ79315557
Hypothetical functions of toxin-antitoxin systemsQ24675719
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Bacteriophage-resistant mutants in Yersinia pestis: identification of phage receptors and attenuation for miceQ28477274
High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) InhibitorsQ28550324
A widespread bacteriophage abortive infection system functions through a Type IV toxin-antitoxin mechanism.Q29346578
High temperature and bacteriophages can indirectly select for bacterial pathogenicity in environmental reservoirsQ33851336
Biocontrol of Escherichia coli O157 with O157-specific bacteriophagesQ34012025
Bacteriophage resistance mechanismsQ34021879
Bacteriophages: potential treatment for bacterial infectionsQ34120000
Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species.Q34293002
Phage-driven loss of virulence in a fish pathogenic bacteriumQ34544436
Phage therapy as an approach to prevent Vibrio anguillarum infections in fish larvae productionQ34612392
Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communitiesQ34637653
Phenotypic resistance and the dynamics of bacterial escape from phage controlQ35151582
Molecular interaction between bacteriophage and the gram-negative cell envelopeQ35449416
Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacyQ35575223
The MazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus aureusQ35597691
Population and evolutionary dynamics of phage therapyQ35709197
Similarity of tetracycline resistance genes isolated from fish farm bacteria to those from clinical isolatesQ35943400
Experimental evolution and bacterial resistance: (co)evolutionary costs and trade-offs as opportunities in phage therapy researchQ36105796
The phage-shock-protein response.Q36207908
Infrared spectroscopy of proteinsQ36907942
Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.Q37389925
Phage shock protein, a stress protein of Escherichia coliQ37680339
Phage choice, isolation, and preparation for phage therapy.Q37705520
Overall biochemical changes in bacteria photosensitized with cationic porphyrins monitored by infrared spectroscopy.Q38881809
Occurrence and significance of atypical Aeromonas salmonicida in non-salmonid and salmonid fish species: a reviewQ39592725
IR spectroscopy as a new tool for evidencing antitumor drug signaturesQ39878591
Early contacts between substrate proteins and TatA translocase component in twin-arginine translocationQ39936045
Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli.Q40465988
Bacteriophages with potential to inactivate Salmonella Typhimurium: Use of single phage suspensions and phage cocktailsQ40776743
Lysis from withoutQ41839843
Heterogeneous nucleotide occupancy stimulates functionality of phage shock protein F, an AAA+ transcriptional activator.Q42598330
Identification of the host determinant of two prolate-headed phages infecting Lactococcus lactisQ42598368
Three small, cryptic plasmids from Aeromonas salmonicida subsp. salmonicida A449.Q42606692
Alterations of Escherichia coli envelope as a consequence of photosensitization with tetrakis(N-ethylpyridinium-4-yl)porphyrin tetratosylateQ43714213
FTIR spectroscopy studies of nucleic acid damage.Q44601048
The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella entericaQ44871944
Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250.Q45012593
Attenuated virulence of an Aeromonas salmonicida subsp. salmonicida type III secretion mutant in a rainbow trout modelQ48134888
Identification of a new member of the phage shock protein response in Escherichia coli, the phage shock protein G (PspG).Q50096031
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectphage therapyQ611870
Aeromonas salmonicidaQ4688338
P577publication date2018-03-08
P1433published inAntibiotics (Basel, Switzerland)Q27725829
P1476titleProtein Expression Modifications in Phage-Resistant Mutants of Aeromonas salmonicida after AS-A Phage Treatment.
P478volume7

Search more.